Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Prior Relapse, Ongoing Alcohol Consumption, and Failure to Engage in Treatment Predict Alcohol Relapse After Liver Transplantation.

Deutsch-Link S, Weinrieb RM, Jones LS, Solga SF, Weinberg EM, Serper M.

Dig Dis Sci. 2019 Nov 9. doi: 10.1007/s10620-019-05937-4. [Epub ahead of print]

PMID:
31707529
2.

Outbreak of Hypervirulent Multidrug-resistant Klebsiella variicola Causing High Mortality in Neonates in Bangladesh.

Farzana R, Jones LS, Rahman MA, Andrey DO, Sands K, Portal E, Watkins WJ, Pervin M, Banerjee M, Walsh TR.

Clin Infect Dis. 2019 Mar 19;68(7):1225-1227. doi: 10.1093/cid/ciy778.

PMID:
30204843
3.

Serologic Detection of Antibodies Targeting the Leukocidin LukAB Strongly Predicts Staphylococcus aureus in Children With Invasive Infection.

Wood JB, Jones LS, Soper NR, Xu M, Torres VJ, Buddy Creech C, Thomsen IP.

J Pediatric Infect Dis Soc. 2019 May 11;8(2):128-135. doi: 10.1093/jpids/piy017.

4.

Commercial Intravenous Immunoglobulin Preparations Contain Functional Neutralizing Antibodies against the Staphylococcus aureus Leukocidin LukAB (LukGH).

Wood JB, Jones LS, Soper NR, Nagarsheth M, Creech CB, Thomsen IP.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e00968-17. doi: 10.1128/AAC.00968-17. Print 2017 Nov.

5.

Comparison of Clinical Trial and Systematic Review Outcomes for the 4 Most Prevalent Eye Diseases.

Saldanha IJ, Lindsley K, Do DV, Chuck RS, Meyerle C, Jones LS, Coleman AL, Jampel HD, Dickersin K, Virgili G.

JAMA Ophthalmol. 2017 Sep 1;135(9):933-940. doi: 10.1001/jamaophthalmol.2017.2583.

6.

Monoclonal Antibodies Against the Staphylococcus aureus Bicomponent Leukotoxin AB Isolated Following Invasive Human Infection Reveal Diverse Binding and Modes of Action.

Thomsen IP, Sapparapu G, James DBA, Cassat JE, Nagarsheth M, Kose N, Putnam N, Boguslawski KM, Jones LS, Wood JB, Creech CB, Torres VJ, Crowe JE Jr.

J Infect Dis. 2017 Apr 1;215(7):1124-1131. doi: 10.1093/infdis/jix071.

7.

Pleural effusion: An uncommon manifestation of nitrofurantoin-induced pulmonary injury.

Davis JW, Jones LS.

Respir Med Case Rep. 2016 Jul 20;19:65-7. doi: 10.1016/j.rmcr.2016.07.009. eCollection 2016.

8.

Right iliac fossa pain from a grossly enlarged and torted appendix in a patient with known colitis.

Seager A, Gill M, Jones LS.

Ann R Coll Surg Engl. 2016 Sep;98(7):e136-7. doi: 10.1308/rcsann.2016.0179. Epub 2016 Jun 8.

9.

Post-vaccination MDEM associated with MOG antibody in a subclinical Chlamydia infected boy.

Azumagawa K, Nomura S, Shigeri Y, Jones LS, Sato DK, Nakashima I, Kashiwagi M, Tanabe T, Shimakawa S, Nakajima H, Tamai H.

Brain Dev. 2016 Aug;38(7):690-3. doi: 10.1016/j.braindev.2016.02.004. Epub 2016 Feb 24.

PMID:
26922251
10.

Host response to Staphylococcus aureus cytotoxins in children with cystic fibrosis.

Chadha AD, Thomsen IP, Jimenez-Truque N, Soper NR, Jones LS, Sokolow AG, Torres VJ, Creech CB.

J Cyst Fibros. 2016 Sep;15(5):597-604. doi: 10.1016/j.jcf.2015.12.023. Epub 2016 Jan 25.

11.

The Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GSK1322322 in Healthy Volunteers.

Naderer O, Jones LS, Zhu J, Coffin MD, Kurtinecz M, Dumont E.

Clin Pharmacol Drug Dev. 2015 Jan;4(1):49-55. Epub 2014 Oct 27.

12.

Pharmacokinetics of hepatitis C virus NS5A inhibitor JNJ-56914845 (GSK2336805) in subjects with hepatic impairment.

Adkison KK, Gan J, Elko-Simms L, Gardner S, Dumont E, Jones LS, Saunders J, Marbury T, Smith W, Berg J, Galloway C, Stump PJ.

J Clin Pharmacol. 2015 Sep;55(9):1042-50. doi: 10.1002/jcph.512. Epub 2015 May 25.

PMID:
25857714
13.

Comparison of Cancer-specific and General Health Literacy Assessments in an Educated Population: Correlations and Modifying Factors.

Jenkins WD, Zahnd WE, Spenner A, Wiley C, Roles R, Potini Y, Jones LS.

J Cancer Educ. 2016 Jun;31(2):268-71. doi: 10.1007/s13187-015-0816-1.

PMID:
25820603
14.

Characterization of plasmids in extensively drug-resistant acinetobacter strains isolated in India and Pakistan.

Jones LS, Carvalho MJ, Toleman MA, White PL, Connor TR, Mushtaq A, Weeks JL, Kumarasamy KK, Raven KE, Török ME, Peacock SJ, Howe RA, Walsh TR.

Antimicrob Agents Chemother. 2015 Feb;59(2):923-9. doi: 10.1128/AAC.03242-14. Epub 2014 Nov 24.

15.

Effects of omeprazole and ritonavir on absorption and elimination of the hepatitis C virus NS5A inhibitor GSK2336805 in healthy adults.

Adkison KK, Jones LS, Lou Y, Gan J, Wilfret DA.

Clin Pharmacol Drug Dev. 2014 Sep;3(5):338-45. doi: 10.1002/cpdd.104. Epub 2014 Feb 18.

PMID:
27129005
16.

Safety, tolerability, and efficacy of GSK1322322 in the treatment of acute bacterial skin and skin structure infections.

Corey R, Naderer OJ, O'Riordan WD, Dumont E, Jones LS, Kurtinecz M, Zhu JZ.

Antimicrob Agents Chemother. 2014 Nov;58(11):6518-27. doi: 10.1128/AAC.03360-14. Epub 2014 Aug 18.

17.

Plasmid carriage of bla NDM-1 in clinical Acinetobacter baumannii isolates from India.

Jones LS, Toleman MA, Weeks JL, Howe RA, Walsh TR, Kumarasamy KK.

Antimicrob Agents Chemother. 2014 Jul;58(7):4211-3. doi: 10.1128/AAC.02500-14. Epub 2014 Apr 21.

18.

The multiplicity of post-translational modifications in pro-opiomelanocortin-derived peptides.

Yasuda A, Jones LS, Shigeri Y.

Front Endocrinol (Lausanne). 2013 Dec 2;4:186. doi: 10.3389/fendo.2013.00186. Review.

19.

Penetration of GSK1322322 into epithelial lining fluid and alveolar macrophages as determined by bronchoalveolar lavage.

Naderer OJ, Rodvold KA, Jones LS, Zhu JZ, Bowen CL, Chen L, Dumont E.

Antimicrob Agents Chemother. 2014;58(1):419-23. doi: 10.1128/AAC.01836-13. Epub 2013 Nov 4.

20.

Safety, tolerability, and pharmacokinetics of oral and intravenous administration of GSK1322322, a peptide deformylase inhibitor.

Naderer OJ, Jones LS, Zhu J, Kurtinecz M, Dumont E.

J Clin Pharmacol. 2013 Nov;53(11):1168-76. doi: 10.1002/jcph.150. Epub 2013 Aug 13.

PMID:
23907665
21.

Application of multiplexed kinase inhibitor beads to study kinome adaptations in drug-resistant leukemia.

Cooper MJ, Cox NJ, Zimmerman EI, Dewar BJ, Duncan JS, Whittle MC, Nguyen TA, Jones LS, Ghose Roy S, Smalley DM, Kuan PF, Richards KL, Christopherson RI, Jin J, Frye SV, Johnson GL, Baldwin AS, Graves LM.

PLoS One. 2013 Jun 24;8(6):e66755. doi: 10.1371/journal.pone.0066755. Print 2013.

22.

Safety, tolerability and pharmacokinetics of orally inhaled zanamivir: a randomized study comparing Rotacap/Rotahaler and Rotadisk/Diskhaler in healthy adults.

Weller S, Jones LS, Lou Y, Piscitelli S, Peppercorn A, Ng-Cashin J.

Antivir Ther. 2013;18(6):827-30. doi: 10.3851/IMP2631. Epub 2013 May 21.

PMID:
23696221
23.

Pharmacokinetics of zanamivir following intravenous administration to subjects with and without renal impairment.

Weller S, Jones LS, Lou Y, Peppercorn A, Ng-Cashin J.

Antimicrob Agents Chemother. 2013 Jul;57(7):2967-71. doi: 10.1128/AAC.02330-12. Epub 2013 Apr 15.

24.

A survey of ocular diseases in an isolated rural Haitian community: a retrospective evaluation.

Duong HV, Westfield KC, Jones LS, Mitchell J, Carr T.

J Natl Med Assoc. 2012 Nov-Dec;104(11-12):536-43.

PMID:
23560356
25.

Safety, tolerability and pharmacokinetics of repeat dosing of the antibiotic GSK1322322, a peptide deformylase inhibitor: a randomized placebo-controlled study.

Naderer OJ, Dumont E, Zhu J, Kurtinecz M, Jones LS.

J Antimicrob Chemother. 2013 Aug;68(8):1901-9. doi: 10.1093/jac/dkt097. Epub 2013 Apr 3.

PMID:
23557930
26.

Effect of H2 blockade and food on single-dose pharmacokinetics of GSK1322322, a peptide deformylase inhibitor antibacterial.

Naderer OJ, Dumont E, Zhu J, Kurtinecz M, Jones LS.

Antimicrob Agents Chemother. 2013 Jun;57(6):2556-61. doi: 10.1128/AAC.02505-12. Epub 2013 Mar 25.

27.

Single-dose safety, tolerability, and pharmacokinetics of the antibiotic GSK1322322, a novel peptide deformylase inhibitor.

Naderer OJ, Dumont E, Zhu J, Kurtinecz M, Jones LS.

Antimicrob Agents Chemother. 2013 May;57(5):2005-9. doi: 10.1128/AAC.01779-12. Epub 2013 Feb 12.

28.

Applicants' choice of an ophthalmology residency program.

Yousuf SJ, Kwagyan J, Jones LS.

Ophthalmology. 2013 Feb;120(2):423-7. doi: 10.1016/j.ophtha.2012.07.084. Epub 2012 Oct 18.

29.

Enucleation and evisceration: 20 years of experience.

Yousuf SJ, Jones LS, Kidwell ED Jr.

Orbit. 2012 Aug;31(4):211-5. doi: 10.3109/01676830.2011.639477. Epub 2012 May 29.

PMID:
22642653
30.

Ocular findings in human immunodeficiency virus patients in Washington, DC.

Kaleem MA, Ramsahai S, Del Fierro K, Rasul S, Onumah C, Lerebours V, Gajjala J, Copeland RA, Jones LS.

Int Ophthalmol. 2012 Apr;32(2):145-51. doi: 10.1007/s10792-012-9543-3. Epub 2012 Mar 27.

PMID:
22450559
31.

Infrared fluorescence imaging of lymphatic regeneration in nonhuman primate facial vascularized composite allografts.

Mundinger GS, Narushima M, Hui-Chou HG, Jones LS, Ha JS, Shipley ST, Drachenberg CB, Dorafshar AH, Koshima I, Bartlett ST, Barth RN, Rodriguez ED.

Ann Plast Surg. 2012 Mar;68(3):314-9. doi: 10.1097/SAP.0b013e31824671e5.

PMID:
22356782
32.

Ophthalmology Residency Match outcomes for 2011.

Yousuf SJ, Jones LS.

Ophthalmology. 2012 Mar;119(3):642-6. doi: 10.1016/j.ophtha.2011.09.060. Epub 2012 Jan 3.

PMID:
22218141
33.

Tunneled superficial inferior epigastric artery (SIEA) myocutaneous/vascularized femur chimeric flaps: a model to study the role of vascularized bone marrow in composite allografts.

Mundinger GS, Kelamis JA, Kim SH, Magarakis M, Jones LS, Ha JS, Rodriguez ED.

Microsurgery. 2012 Feb;32(2):128-35. doi: 10.1002/micr.20957. Epub 2011 Nov 24.

PMID:
22113953
34.

Nonhuman primate model of fibula vascularized composite tissue allotransplantation demonstrates donor-recipient bony union.

Mundinger GS, Nam AJ, Hui-Chou HG, Stanwix MG, Jones LS, Drachenberg CB, Kukuruga D, Shipley ST, Dorafshar AH, Panda A, Bartlett ST, Barth RN, Rodriguez ED.

Plast Reconstr Surg. 2011 Dec;128(6):1193-204. doi: 10.1097/PRS.0b013e318230c5d0.

PMID:
21841529
35.

Vascularized bone marrow-based immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates.

Barth RN, Rodriguez ED, Mundinger GS, Nam AJ, Ha JS, Hui-Chou H, Jones LS, Panda A, Shipley ST, Drachenberg CB, Kukuruga D, Bartlett ST.

Am J Transplant. 2011 Jul;11(7):1407-16. doi: 10.1111/j.1600-6143.2011.03551.x. Epub 2011 Jun 10.

36.

Incorporating Scientific Publishing into an Undergraduate Neuroscience Course: A Case Study Using IMPULSE.

Jones LS, Allen L, Cronise K, Juneja N, Kohn R, McClellan K, Miller A, Nazir A, Patel A, Sweitzer SM, Vickery E, Walton A, Young R.

J Undergrad Neurosci Educ. 2011 Spring;9(2):A84-91. Epub 2011 Mar 15.

37.

Adherence to topical glaucoma medication during hospitalization.

Yousuf SJ, Jones LS.

J Glaucoma. 2011 Dec;20(9):573-6. doi: 10.1097/IJG.0b013e3181f4661b.

PMID:
21048511
38.

Abdominal ventral hernia repair with current biological prostheses: an experimental large animal model.

Stanwix MG, Nam AJ, Hui-Chou HG, Ferrari JP, Aberman HM, Hawes ML, Keledjian KM, Jones LS, Rodriguez ED.

Ann Plast Surg. 2011 Apr;66(4):403-9. doi: 10.1097/SAP.0b013e3181e051ed.

PMID:
21042180
39.

A unique approach to continuity of care 24/7 infusion.

Weeks SK, Green SR, Jones LS.

Nurs Manage. 2009 Aug;40(8):39-42. doi: 10.1097/01.NUMA.0000359208.34403.49. No abstract available.

PMID:
19667919
40.

Hyperemic maximal venous outflow unmasks symptomatic lower extremity venous obstruction.

Paolini DJ, Jones LS, Comerota AJ.

J Vasc Surg. 2008 Sep;48(3):749-53. doi: 10.1016/j.jvs.2008.03.038.

41.

Lower extremity arterial inflow is adversely affected in patients with venous disease.

Paolini DJ, Comerota AJ, Jones LS.

J Vasc Surg. 2008 Oct;48(4):960-4. doi: 10.1016/j.jvs.2008.05.058. Epub 2008 Jul 17.

42.

Chemical reactivities and physical effects in comparison between tocopherols and tocotrienols: physiological significance and prospects as antioxidants.

Yoshida Y, Saito Y, Jones LS, Shigeri Y.

J Biosci Bioeng. 2007 Dec;104(6):439-45. doi: 10.1263/jbb.104.439. Review.

PMID:
18215628
43.
44.

The ethics of transcranial magnetic stimulation.

Jones LS.

Science. 2007 Mar 23;315(5819):1663-4; author reply 1663-4. No abstract available.

PMID:
17379789
45.

Genomewide scan and fine mapping of quantitative trait loci for intraocular pressure on 5q and 14q in West Africans.

Rotimi CN, Chen G, Adeyemo AA, Jones LS, Agyenim-Boateng K, Eghan BA Jr, Zhou J, Doumatey A, Lashley K, Huang H, Fasanmade O, Akinsola FB, Ezepue F, Amoah A, Akafo S, Chen Y, Oli J, Johnson T.

Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3262-7.

PMID:
16877390
46.

A systematic approach to stabilizing EBA-175 RII-NG for use as a malaria vaccine.

Peek LJ, Brandau DT, Jones LS, Joshi SB, Middaugh CR.

Vaccine. 2006 Jul 26;24(31-32):5839-51. Epub 2006 May 12.

PMID:
16735084
47.

An undergraduate course on publishing in neuroscience.

Jones LS, Black LC, Bright L, Meekins C, Thakur V, Warren C.

J Undergrad Neurosci Educ. 2006 Spring;4(2):A60-7. Epub 2006 Jun 15.

48.

Ritonavir increases plasma amprenavir (APV) exposure to a similar extent when coadministered with either fosamprenavir or APV.

Wire MB, Baker KL, Jones LS, Shelton MJ, Lou Y, Thomas GJ, Berrey MM.

Antimicrob Agents Chemother. 2006 Apr;50(4):1578-80.

49.

Secondary structures of proteins adsorbed onto aluminum hydroxide: infrared spectroscopic analysis of proteins from low solution concentrations.

Dong A, Jones LS, Kerwin BA, Krishnan S, Carpenter JF.

Anal Biochem. 2006 Apr 15;351(2):282-9. Epub 2006 Jan 24.

PMID:
16460655
50.

Primary malignant melanoma of the colon in an oculocutaneous albino.

McNicol FJ, Jones LS.

Surgeon. 2005 Oct;3(5):358-9.

PMID:
16245656

Supplemental Content

Loading ...
Support Center